Skip to content

A Safety Study of PF-08046040/SEA-CD70 in Patients with Myeloid Malignancies

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-506945-42-00
Acronym
SGNS70-101
Enrollment
8
Registered
2023-09-15
Start date
2022-01-21
Completion date
Unknown
Last updated
2026-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myeloid leukaemia, Myeloid malignancies

Interventions

None listed

Sponsors

Seagen Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026